Pembrolizumab vs Sumatriptan
Pembrolizumab vs Sumatriptan: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Sumatriptan.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Sumatriptan: Selective 5-HT1B/1D receptor agonist.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Sumatriptan — 2.5 hours.
Chemical Properties
Molecular Formula: Sumatriptan — C14H21N3O2S.
Molecular Weight: Sumatriptan — 295.4020 g/mol.
Type: Pembrolizumab — Antibody; Sumatriptan — Small molecule.